Here's Why Allakos Inc. (ALLK) is Poised for a Turnaround After Losing -61.36% in 4 Weeks — Jan 18th, 2024

Allakos Inc. (ALLK) has been beaten down lately with too much selling pressure. While the stock has lost 61.4% over the past four weeks, there is light at the end of the tunnel as it is now in oversold territory and Wall Street analysts expect the company to report better earnings than the...

Biotech Stock Roundup: VRTX/CRSP Gene Therapy Label Expansion, ALLK Falls on Update — Jan 18th, 2024

It was a low-key week for the biotech sector with no major updates. Regulatory and pipeline updates from a few players were in focus. Recap of the Week’s Most Important Stories: Vertex, CRSP Gene Therapy Label Expansion: Vertex Pharmaceuticals VRTX and partner CRISPR Therapeutics CRSP ...